公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2015 | Geographic Variation of Chronic Kidney Disease Prevalence: Correlation with the Incidence of Renal Cell Carcinoma or Urothelial Carcinoma? | Yap Y.-S.; Chuang K.-W.; CHUN-JU CHIANG ; Chuang H.-Y.; Lu S.-N. | BioMed Research International | 1 | 1 | |
2022 | HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis | Tan R.S.Y.C.; Ong W.S.; Lee K.-H.; Lim A.H.; Park S.; Park Y.H.; CHING-HUNG LIN ; YEN-SHEN LU ; Ono M.; Ueno T.; Naito Y.; Onishi T.; Lim G.-H.; Tan S.-M.; Lee H.-B.; Ryu H.S.; Han W.; Tan V.K.M.; Wong F.-Y.; Im S.-A.; Tan P.H.; Chan J.Y.; Yap Y.-S. | BMC Medicine | 53 | 41 | |
2019 | Insights into Breast Cancer in the East vs the West: A Review | Yap Y.-S.; YEN-SHEN LU ; Tamura K.; Lee J.E.; Ko E.Y.; Park Y.H.; Cao A.-Y.; CHING-HUNG LIN ; Toi M.; Wu J.; Lee S.-C. | JAMA Oncology | 84 | 66 | |
2021 | An Overview of the Treatment Efficacy and Side Effect Profile of Pharmacological Therapies in Asian Patients with Breast Cancer | YEN-SHEN LU ; Yeo W.; Yap Y.-S.; Park Y.H.; Tamura K.; Li H.; Cheng R. | Targeted Oncology | 5 | 5 | |
2020 | Palbociclib and beyond for the treatment of HR + HER2- metastatic breast cancer: an Asian-Pacific perspective and practical management guide on the use of CDK4/6 inhibitors | Dawood S.; Chiu J.W.-Y.; CHIUN-SHENG HUANG ; Nag S.; Sookprasert A.; Yap Y.-S.; Md Yusof M. | Current Medical Research and Opinion | 5 | 5 | |
2021 | Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs | Hata T.; Nakamura K.; Yonemori K.; Noguchi E.; Watanabe M.; Sohn J.; YEN-SHEN LU ; Yap Y.-S.; Tamura K.; Fujiwara Y. | Clinical and Translational Science | 2 | 1 |